Created in 2004 (United States), Taligen Therapeutics own 585 sister brands and 17478 competing brands. Taligen Therapeutics is owned by ASTRAZENECA, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB0009895292. Taligen Therapeutics belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
ASTRAZENECA
(Taligen Therapeutics)
over 5 years*
GBX 24,736.19